Connecticut Children’s First Children’s Hospital in State to Deploy Nym’s Coding Technology to Automate Medical Billing to Improve Patient Care Journeys

2 years ago

Nym’s Coding Engine Automates Revenue Cycle Management for Level 1 Pediatric Trauma Center, Bringing Greater Accuracy, Efficiency and Speed to…

Real Chemistry Reports 2021 Business Results

2 years ago

Transformational year highlighted by global revenue of $475 million and 36% growth SAN FRANCISCO--(BUSINESS WIRE)--Real Chemistry, a global health innovation…

PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System

2 years ago

First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South…

SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India

2 years ago

The collaboration focuses on SphingoTec's near patient diagnostic solution for critical care settings.Rivaara gains exclusive rights to market and distribute…

AlzeCure Presents New Data at AD/PD Meeting on NeuroRestore’s Positive Effect on Mitochondrial Function

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…

Promore Pharma has Reached Recruitment Goal in Clinical Trial of Ensereptide

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 17 March 2022 - Promore Pharma AB,…

5 Dosell are Implemented in a New Municipality

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 17, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe…

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer

2 years ago

Study further highlights potential of RaDaR to stratify patients and improve treatment outcomesFT. MYERS, FL / ACCESSWIRE / March 17,…

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

2 years ago

Despite Primary Endpoint not Being Met, Due to Small Sample Size, Results Show a Very Positive Trend in Efficacy Parameters…

LG’S NEW HEALTHCARE INNOVATION CENTER FEATURED AT GLOBAL HEALTH CONFERENCE

2 years ago

Virtual Tour Highlights Solutions for Medical Environments From ORs and Nurse Stations to Patient Rooms, Tele-Health and More ORLANDO, Fla.,…